AKINETON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Akineton, and when can generic versions of Akineton launch?
Akineton is a drug marketed by Abbvie and is included in two NDAs.
The generic ingredient in AKINETON is biperiden hydrochloride. There are five drug master file entries for this compound. Additional details are available on the biperiden hydrochloride profile page.
Summary for AKINETON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 45 |
Clinical Trials: | 3 |
Patent Applications: | 3,735 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AKINETON at DailyMed |
Recent Clinical Trials for AKINETON
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
PROADI-SUS | Phase 3 |
Ministry of Health, Brazil | Phase 3 |
Hospital Sirio-Libanes | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for AKINETON
US Patents and Regulatory Information for AKINETON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | AKINETON | biperiden lactate | INJECTABLE;INJECTION | 012418-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbvie | AKINETON | biperiden hydrochloride | TABLET;ORAL | 012003-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |